IASO BIOMED, INC. - Statements of Operations - USD ($)	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Income Statement
Revenues
Operating Expenses:
General and administrative	543,326	166,446
Research and development	171,078	444,007
Total operating expenses	714,405	610,453
Loss From Operations	(714,405)	(610,453)
Other Expenses:
Interest expense, related party	2,009	197
Total other expenses	2,009	197
Net Loss	$ (716,413)	$ (610,650)
Earnings per Common Share:
Basic and diluted loss per share	$ (0.02)	$ (0.02)
Weighted average number of common shares outstanding:
Basic and diluted	33,837,920	32,518,353